1q and the pathogenesis of MM
Samir Parekh
Mutational signatures and the evolution of MM
Francesco Maura
Evolving insights into the t(4;14)
Gareth Morgan
Update on ubiquitin ligases, Celmods and new IMiDs
Ken Anderson
Targeting MCL1 and BCL2 inhibition
Larry Boise
Therapeutic trials in MGUS and SMM
Maria V Mateos
PIKfyve- a novel target in Myeloma
Keith Stewart
The MM niche, quiescence and BMP6
Sarah Gooding
Single cell analysis of myeloma and its microenvironment
Irene Ghobrial
The current therapeutic standard for MM
Pieter Sonneveld
Molecular and clinical definitions of high-risk MM
Leif Bergsagel
Genetic changes associated with relapse
Jonathan Keats
Clinical data and trial data on bispecific antibodies for MM
Hermann Einsele
Clinical data and trial update of anti-BCMA CAR-Ts
Yi Lin
Optimizing and manufacturing CAR-T constructs
Eric Smith